Your browser doesn't support javascript.
loading
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723].
Fossard, G; Broussais, F; Coelho, I; Bailly, S; Nicolas-Virelizier, E; Toussaint, E; Lancesseur, C; Le Bras, F; Willems, E; Tchernonog, E; Chalopin, T; Delarue, R; Gressin, R; Chauchet, A; Gyan, E; Cartron, G; Bonnet, C; Haioun, C; Damaj, G; Gaulard, P; Fornecker, L; Ghesquières, H; Tournilhac, O; Gomesda Silva, M; Bouabdallah, R; Salles, G; Bachy, E.
Affiliation
  • Fossard G; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France; Claude Bernard Lyon 1 University, Lyon, France; Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France.
  • Broussais F; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France.
  • Coelho I; Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal.
  • Bailly S; Hematology and Cell Therapy Department, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France; Clermont Auvergne University, Clermont-Ferrand, France.
  • Nicolas-Virelizier E; Hematology Department, Centre Leon Berard, Lyon, France.
  • Toussaint E; Hematology Department, CHU de Strasbourg, Strasbourg, France.
  • Lancesseur C; Hematology Institute, CHU de Caen, Caen, France.
  • Le Bras F; Hematology Department, CHU Henri Mondor, Creteil, France.
  • Willems E; Hematology Department, CHU de Liège, Liège, Belgium.
  • Tchernonog E; Hematology Department, CHU de Montpellier, Montpellier, France.
  • Chalopin T; Hematology Department, CHU de Tours, Tours, France.
  • Delarue R; Hematology Department, CHU Necker Enfants Malades, AP-HP, Paris, France.
  • Gressin R; Hematology Department, CHU de Grenoble, Grenoble, France.
  • Chauchet A; Hematology Department, CHU de Besançon, Besançon, France.
  • Gyan E; Hematology Department, CHU de Tours, Tours, France.
  • Cartron G; Hematology Department, CHU de Montpellier, Montpellier, France.
  • Bonnet C; Hematology Department, CHU de Liège, Liège, Belgium.
  • Haioun C; Hematology Department, CHU Henri Mondor, Creteil, France.
  • Damaj G; Hematology Institute, CHU de Caen, Caen, France.
  • Gaulard P; Hematology Department, CHU Henri Mondor, Creteil, France.
  • Fornecker L; Hematology Department, CHU de Strasbourg, Strasbourg, France.
  • Ghesquières H; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France.
  • Tournilhac O; Hematology and Cell Therapy Department, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France; Clermont Auvergne University, Clermont-Ferrand, France.
  • Gomesda Silva M; Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal.
  • Bouabdallah R; Hematology Department, Institut Paoli Calmette, Marseille, France.
  • Salles G; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France; Claude Bernard Lyon 1 University, Lyon, France; Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France.
  • Bachy E; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France; Claude Bernard Lyon 1 University, Lyon, France; Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France. Electronic address: emmanuel.bachy@chu-lyon.fr.
Ann Oncol ; 32(7): 945, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33992519

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: